1.
Journal of International Oncology
;
(12): 515-517, 2014.
Artigo
em Chinês
| WPRIM
| ID: wpr-671869
RESUMO
Epidermalgrowthfactorreceptor-tyrosinekinaseinhibitor(EGFR-TKI)resistanceinnon-small cell lung cancer(NSCLC)has become more and more common,which includes primary and secondary resistance.The primary resistance is mainly related with EGFR gene mutation,and the secondary resistant is mainly related with T790M,MET and other genes.